Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Joanne KotsopoulosJacek GronwaldTomasz HuzarskiAmber AeiltsSusan Randall ArmelBeth KarlanChristian F SingerAndrea EisenNadine TungOlufunmilayo OlopadeLouise BordeleauCharis EngWilliam D FoulkesSusan L NeuhausenCarey A CullinaneTuya PalRobert FruscioJan LubinskiKelly MetcalfePing SunSteven A Narodnull nullPublished in: Breast cancer research and treatment (2023)
Chemoprevention may be an effective risk-reduction option for BRCA mutation carriers, but further studies with longer follow-up are necessary.